The Beauty Tech Group (LON:TBTG – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday. The company traded as high as GBX 491 and last traded at GBX 491, with a volume of 143,350 shares. The stock had previously closed at GBX 486.
Analysts Set New Price Targets
A number of analysts have weighed in on TBTG shares. Berenberg Bank increased their target price on shares of The Beauty Tech Group from GBX 550 to GBX 600 and gave the company a “buy” rating in a research report on Thursday, September 17th. Canaccord Genuity Group raised their price target on shares of The Beauty Tech Group from GBX 545 to GBX 600 and gave the stock a “buy” rating in a report on Tuesday, September 22nd. Two research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, The Beauty Tech Group currently has a consensus rating of “Buy” and a consensus price target of GBX 600.
Check Out Our Latest Research Report on The Beauty Tech Group
The Beauty Tech Group Price Performance
The firm has a market cap of £520.38 million and a price-to-earnings ratio of 26.48. The firm’s fifty day moving average is GBX 405.90 and its 200-day moving average is GBX 339.34.
The Beauty Tech Group (LON:TBTG – Get Free Report) last issued its quarterly earnings results on Thursday, September 17th. The beauty technology company reported GBX 11.80 earnings per share for the quarter.
The Beauty Tech Group Company Profile
The Beauty Tech Group is a UK-headquartered beauty technology company focused on developing, marketing and selling clinically backed at-home beauty devices and related skincare products. The group operates a portfolio of category-leading brands, including CurrentBody Skin, ZIIP Beauty and Tria Laser, and offers products built around core aesthetic technologies used in professional settings, including LED light therapy, radio frequency, microcurrent and laser treatments.
Featured Stories
- Five stocks we like better than The Beauty Tech Group
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for The Beauty Tech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Beauty Tech Group and related companies with MarketBeat.com's FREE daily email newsletter.
